Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study

Nanoparticle albumin-bound paclitaxel and PD-1 inhibitor (sintilimab) combination therapy for soft tissue sarcoma: a retrospective study

Abstract Background There is increasing evidence that combination therapy with nanoparticle albumin-bound paclitaxel (nab-paclitaxel) and programmed cell death protein 1 (PD-1) inhibitor is safe and efficacious in treating many types of malignant tumors. However, clinical data demonstrating the effe...

Full description

Bibliographic Details
Main Authors:	Zhichao Tian, Shuping Dong, Yang Yang, Shilei Gao, Yonghao Yang, Jinpo Yang, Peng Zhang, Xin Wang, Weitao Yao
Format:	Article
Language:	English
Published:	BMC 2022-01-01
Series:	BMC Cancer
Subjects:	Nanoparticle albumin-bound paclitaxel PD-1 inhibitor Programmed cell death protein 1 Sintilimab Soft tissue sarcoma Angiosarcoma
Online Access:	https://doi.org/10.1186/s12885-022-09176-1

Similar Items

Albumin-bound paclitaxel and gemcitabine combination therapy in soft tissue sarcoma
by: Zhichao Tian, et al.
Published: (2020-07-01)

Efficacy and safety of sintilimab plus albumin-bound-paclitaxel in recurrent or metastatic cervical cancer: a multicenter, open-label, single-arm, phase II trialResearch in context
by: Yin Wang, et al.
Published: (2023-11-01)

Albumin-Bound Paclitaxel: Worthy of Further Study in Sarcomas
by: Zhichao Tian, et al.
Published: (2022-02-01)

Combining nanoparticle albumin-bound paclitaxel with camrelizumab in advanced soft tissue sarcoma: activity, safety, and future perspectives
by: Zhichao Tian, et al.
Published: (2024-02-01)

Sintilimab plus nab-paclitaxel as second-line treatment for advanced biliary tract cancer: study protocol for an investigator-initiated phase 2 trial (NapaSinti trial)
by: Nan Zhou, et al.
Published: (2023-08-01)

Evaluate the Clinical Outcome of Nanoparticle Albumin-bound Paclitaxel on Breast Cancer Treatment: A Systematic Review and Meta-analysis
by: Yasaman Shariati, et al.
Published: (2022-09-01)

Tolerance, Variability and Pharmacokinetics of Albumin-Bound Paclitaxel in Chinese Breast Cancer Patients
by: Qingmei Li, et al.
Published: (2018-11-01)

A case report of hypocalcemia after chemotherapy with albumin‐bound paclitaxel
by: Zhongchao Wang, et al.
Published: (2023-03-01)

Case report: Complete response of a bladder cancer patient with multiple hepatic and pelvic metastases treated by nab-paclitaxel combined with sintilimab
by: Zhu-lei Tao, et al.
Published: (2022-12-01)

Ultra-widefield angiographic imaging of albumin-bound paclitaxel-induced cystoid macular edema
by: Junhyuck Lee, et al.
Published: (2019-01-01)

Nanoparticle Albumin-Bound Paclitaxel- and/or Gemcitabine-Induced Scleroderma Accompanied by Acanthosis Nigricans-Like Skin Changes
by: Sei-ichiro Motegi, et al.
Published: (2019-10-01)

Efficacy and safety of albumin-bound paclitaxel combined with gemcitabine in the treatment of advanced and metastatic pancreatic cancer
by: TIAN Yue, et al.
Published: (2023-09-01)

Nanoparticle albumin-bound paclitaxel – first step of nanotechnology into clinical practice
by: R. N. Alyautdin, et al.
Published: (2022-06-01)

The Efficacy and Safety of Sintilimab Combined With Nab-Paclitaxel as a Second-Line Treatment for Advanced or Metastatic Gastric Cancer and Gastroesophageal Junction Cancer
by: Jianzheng Wang, et al.
Published: (2022-06-01)

Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol
by: Xiangdong Cheng, et al.
Published: (2021-01-01)

Cystoid Macular Edema following Treatment with Nanoparticle Albumin-Bound Paclitaxel and Atezolizumab for Metastatic Breast Cancer
by: Hiroaki Yamane, et al.
Published: (2023-10-01)

Intravitreal Ranibizumab Had Limited Effect on Cystoid Macular Edema Due to Albumin-Bound Paclitaxel: A Case Report and Literature Review
by: Suna Ye, et al.
Published: (2021-12-01)

Albumin-bound paclitaxel augment temozolomide treatment sensitivity of glioblastoma cells by disrupting DNA damage repair and promoting ferroptosis
by: Shanqiang Qu, et al.
Published: (2023-10-01)

Clinical Research on Albumin-bound Paclitaxel-based Therapy in Advanced Lung Cancer
by: Xu LI, et al.
Published: (2017-06-01)

Evaluation of nanoparticle albumin-bound paclitaxel loaded macrophages for glioblastoma treatment based on a microfluidic chip
by: Zuorun Xie, et al.
Published: (2024-03-01)

Efficacy evaluation of albumin-bound paclitaxel combined with carboplatin as neoadjuvant chemotherapy for primary epithelial ovarian cancer
by: Huan Wang, et al.
Published: (2022-06-01)

The efficacy and safety of nanoparticle albumin bound‐paclitaxel‐based regimen as second‐ or third‐line treatment in patients with advanced esophageal squamous cell carcinoma
by: Dao Xin, et al.
Published: (2023-05-01)

MRI-guided microwave ablation and albumin-bound paclitaxel for lung tumors: Initial experience
by: Xiaokang Shen, et al.
Published: (2022-11-01)

Efficacy and safety of sintilimab plus doxorubicin in advanced soft tissue sarcoma: A single-arm, phase II trial
by: Zhichao Tian, et al.
Published: (2022-10-01)

Comparison between nab-paclitaxel and solvent-based taxanes as neoadjuvant therapy in breast cancer: a systematic review and meta-analysis
by: Miao Liu, et al.
Published: (2021-02-01)

A Case of Systemic Severe Bullous Pemphigoid Caused by Long-Term Sintilimab Treatment for Renal Cell Carcinoma
by: He J, et al.
Published: (2022-08-01)

Exceptional Response to Nanoparticle Albumin-Bound Paclitaxel and Gemcitabine in a Patient with a Refractory Adenocarcinoma of the Ampulla of Vater
by: Markus Kapp, et al.
Published: (2016-01-01)

The Efficacy of Combined Cisplatin and Nanoparticle Albumin-Bound Paclitaxel in a Stage IV Pancreatic Squamous Cell Carcinoma Patient With a Somatic BRCA2 Mutation: A Case Report
by: Xiaozhun Huang, et al.
Published: (2021-04-01)

Phase I study of cisplatin and nanoparticle albumin‐bound‐paclitaxel combined with concurrent radiotherapy in locally advanced esophageal squamous cell carcinoma
by: Hui Jiang, et al.
Published: (2023-07-01)

Case report: Undifferentiated sarcoma with multiple tumors involved in Lynch syndrome: Unexpected favorable outcome to sintilimab combined with chemotherapy
by: Jiaying Liu, et al.
Published: (2022-11-01)

Encouraging Pathological Complete Response Rate from Neoadjuvant Chemotherapy with Albumin-Bound Paclitaxel Plus Cisplatin and Capecitabine for Locally Advanced Esophageal Squamous Carcinoma: Preliminary Outcome of a Retrospective Study
by: Zhang W, et al.
Published: (2021-03-01)

Efficacy and safety of camrelizumab combined with albumin-bound paclitaxel as third- or later-line regimen in patients with advanced non-small cell lung cancer
by: Jianfeng Zhu, et al.
Published: (2023-12-01)

Construction of gastric cancer patient-derived organoids and their utilization in a comparative study of clinically used paclitaxel nanoformulations
by: Jiale Zou, et al.
Published: (2022-05-01)

Bioresponsive albumin-conjugated paclitaxel prodrugs for cancer therapy
by: Jincheng Yang, et al.
Published: (2018-01-01)

Diffuse alveolar hemorrhage from metastatic cardiac angiosarcoma of the lung successfully treated with paclitaxel chemotherapy: A case report and brief literature review
by: Jieun Yang, et al.
Published: (2021-01-01)

Cost-effectiveness analysis of sintilimab plus bevacizumab biosimilar compared with lenvatinib as the first-line treatment of unresectable or metastatic hepatocellular carcinoma
by: Ting Zhou, et al.
Published: (2022-11-01)

Interstitial Lung Disease Following Single-Agent Nanoparticle Albumin-Bound Paclitaxel Treatment in Patients with Advanced Non-Small Cell Lung Cancer
by: Yuki Nakatani, et al.
Published: (2017-08-01)

Retrospective analysis of the effectiveness and tolerability of nab‐paclitaxel in Chinese elderly patients with advanced non‐small‐cell lung carcinoma
by: Shuhang Wang, et al.
Published: (2020-05-01)

Favorable response to PD-1 inhibitor plus chemotherapy as first-line treatment for metastatic follicular dendritic cell sarcoma of the spleen: a case report
by: Jielang Li, et al.
Published: (2023-08-01)

Study on the thermal stability of nab-paclitaxel during hyperthermic intraperitoneal chemotherapy
by: Jingjing Zhang, et al.
Published: (2023-03-01)